09989.HK
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 3.94
+1.42%Next report
Analyst consensus
- Next report date
- Apr 1, 2027
- EPS estimate
- HKD 0.12
- Revenue estimate
- HKD 1.4B
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- HKD 0.10
- EPS estimate
- HKD 0.22
- Revenue actual
- HKD 1.4B
- Revenue estimate
- HKD 2.9B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -40.9%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | HKD 0.22 | HKD 0.10 | Miss -57.13% | HKD 1.4B |
| Aug 28, 2026 | HKD 0.09 | HKD 0.07 | Miss -24.68% | HKD 1.4B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 1, 2027